SFI
CVS icon

Susquehanna Fundamental Investments’s CVS Health CVS Stock Holding History

Susquehanna Fundamental Investments’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-30,900
Closed -$2.45M – 532
2025
Q4 		$2.45M Sell
30,900
-424,397
-93% -$33.5M 0.08% 228
2025
Q3 		$34.3M Sell
455,297
-3,341
-0.7% -$229K 1.34% 13
2025
Q2 		$31.6M Sell
458,638
-234,536
-34% -$15.4M 0.85% 18
2025
Q1 		$47M Buy
693,174
+64,634
+10% +$3.87M 0.66% 6
2024
Q4 		$28.2M Buy
+628,540
New +$35.3M 0.4% 36
2024
Q2 		$39.3M Buy
665,451
+145,158
+28% +$9.08M 0.91% 8
2024
Q1 		$41.5M Buy
+520,293
New +$39.7M 1.94% 1
2022
Q4 		– Sell
-47,112
Closed -$4.49M – 1256
2022
Q3 		$4.49M Buy
+47,112
New +$4.66M 0.08% 345
2019
Q2 		– Sell
-72,200
Closed -$3.89M – 359
2019
Q1 		$3.89M Buy
72,200
+45,600
+171% +$2.81M 0.44% 72
2018
Q4 		$1.74M Buy
+26,600
New +$1.99M 0.31% 110
2018
Q3 		– Sell
-42,800
Closed -$2.75M – 360
2018
Q2 		$2.75M Buy
+42,800
New +$2.82M 0.41% 75

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Susquehanna Fundamental Investments's CVS Position: Q1 2026 in Review

Susquehanna Fundamental Investments sold out of CVS Health (CVS) in Q1 2026, closing a stake of 30,900 shares — an estimated $2.45M sold.

Susquehanna Fundamental Investments first reported a position in CVS in Q2 2018 and held it in 11 quarters. The position peaked at $47M in Q1 2025. 1,876 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Susquehanna Fundamental Investments reported no remaining CVS Health position as of Q1 2026 after selling out during the quarter.
  • Susquehanna Fundamental Investments sold 30,900 CVS Health shares in Q1 2026, an estimated $2.45M.
  • Susquehanna Fundamental Investments first reported a position in CVS Health in Q2 2018 and held it in 11 quarters.
  • Susquehanna Fundamental Investments's CVS Health position peaked at $47M in Q1 2025.
  • 1,876 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Susquehanna Fundamental Investments's 13F filing for Q1 2026, filed 15 May 2026.